CLEVELAND--NetGenics has released an enhanced version of its Synergy application framework for drug discovery, featuring the ability to work with Incyte Pharmaceuticals' sequence data and "Distributed Synergy," which enables transparent, real-time data sharing among research teams at multiple sites. "With this release we have achieved our vision of providing an enterprise-scale computing infrastructure for drug discovery," said Manuel Glynias, NetGenics' president and CEO. In addition to demonstrating fully integrated, multisite capability, Glynias said the new version incorporates "some of the industry's most useful data sources and tools, exemplifying the ability of Synergy to provide best-of-breed solutions for pharmaceutical research computing."
The company said that the enhanced product allows users to retrieve, analyze, and annotate LifeSeq sequences without altering native data. It also enables scientists at different sites to have access to tools that were previously unavailable due to geographic separation. Other additions to the product, according to the company, include enhanced bioinformatics functionality, automated nightly updates of GenBank, weekly updates of Swiss-Prot, inclusion of the National Center for Biotechnology Information's Blast 2.0 and Smith Waterman analysis, and improvements to the framework's user interface.